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Respiratory syncytial virus (RSV) is an ubiquitous paramyxovirus belonging to
the genusPneumovirus(1). Natural human RSV infections occurin winter outbreaks,
usually resulting in common cold syndrome. Infants are especially prone to lower
respiratorytractinfection, which is themostcommon single causeofhospitalization
ofthis agegroupinindustrial countries. Vaccinationwithformaldehyde-inactivated
RSV induces neutralizing serum antibodies, but fails to protect against natural in-
fection; moreover, infected vaccinees suffer exacerbatedlung disease. Similarlyvac-
cinated cotton rats showenhanced pathological changes inthe lungs (2), as domice
primed withrecombinant vaccinia viruses expressing single RSV proteins (3). These
methods ofpriming induce both humoral and cellular immune responses to RSV
(2-5). Passive transfer ofmAbs has not been shown to enhance pathology in RSV
infected mice, and some antibodies protect against pulmonary disease (6, 7). Cell-
mediated immunity may therefore play a role in the pathogenesis ofRSV-induced
disease. Although polyclonal memory T cells can clear persistent RSV infection in
immunodeficient mice (8), the role of T cell subpopulations in immunopathology
merits examination.
In this study, we use bronchoalveolarlavage (BAL)to monitor pulmonary disease
in RSV-infected mice, and show enhanced pathologyassociated withaccelerated clear-
ance oflung virus after intravenous transfer of a cytotoxic RSV-specific T cell line
and a CTL clone.
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Materials and Methods
BriefDefinitive Report
Virus Infection.
￿
The human A2 strain ofRSV was grown and assayed for infectivity in
HEp-2 cells (9, 10). Etherized female BALB/c mice (SPF bred at NIMR) were infected in-
tranasally with 2 x 105 plaque-forming units (PFU) of RSV.
TCell Line and Clone.
￿
An RSVspecific T cell line (MJC-A2) was derived from BALB/c
mice primed by infection with RSV. Spleen cells were stimulated with antigen every 7 d in
25-cm2 plastic flasks (Nunc, Roskilde, Denmark; Gibco-BRL, Paisley, Scotland). 3 x 106 T
cells were cultured in 20 ml RPMI/10% FCS with 2 x 10' syngeneic X-irradiated (3,000
rad) spleen cells infected with RSV at a multiplicity of infection (moi) of 0.1 PFU per cell.
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After 4-5 cycles, the cultures were supplemented every 3-4 d with 10% crude IL-2, provided
by 48-h supernatants from Con A-stimulated rat spleen cell cultures. MJC-A2 T cells were
used in adoptive transfer experiments after 15-20 weekly passages. CTL clone E8a was iso-
lated 7 d after the first in vitro antigenic stimulation of spleen cells from primed BALB/c
mice. T cellswere distributed in 96-well plates with syngeneic RSVinfected X-irradiated spleen
cells (5 x 105/well). Cultures were supplemented with 10,70 crude IL-2 (see above) at day
0 and 7. CTL clone E8a was maintained as described above.
TCell Transfers.
￿
BALB/c mice were infected intranasally with RSV A2, and within 3 h
ofinfection, CTL were transferred intravenously in 200 pl HBSS. In some experiments, mice
were irradiated (500 rad, 60Co source) 24 h before infection with RSV and/or transfer of
CTL.
BronchoalveolarLavage (BAL).
￿
Mice were killed with and exsanguinated via the femoral
vessels. The thorax was opened, and 1.2-mm Portex tubing (Portex, Hythe, England) was
introduced to the trachea at the cricothyroid membrane. 1 ml of 12 mM lidocaine hydrochlo-
ride (Astra Pharmaceuticals, King's Langley, England) in PBS was washed in and out six
times over a 1-2-min period to promote elution of adherent cells. 2 ml of hemolytic HBSS
(BSS minus NaCl, plus NH4C1, and 0 .5% gelatin) was added to the eluate for 5 min, and
200 pl was removed for spectrophotometric estimation of hemoglobin (Hb) concentration
at 405 nM. Background absorption at 492 nM was deducted. Hb concentration was expressed
as pg/ml of BAL fluid. Normal BALB/c blood was used as a calibration standard, and as-
sumed to contain 150 mg/ml Hb. The remaining cells were washed, cytospun onto slides,
fixed, and Giemsa stained. Differential counts of300-500 cells were made by oil immersion
lightmicroscopy. Cytotoxicity (see below) was assayed after removal of plastic adherent cells
for 1 h at 37°C .
Cytotoxiciy Assays.
￿
The "Cr-release assay for RSV-specific CTL has been described (9).
Target cells were P815 cells or Kd-transferred L cells (L-Kd), either uninfected, or infected
for 24 h with RSV A2 strain at an moi of 1-2 . L-K' cells were kindly provided by Dr. J.
Maryanski, Ludwig Institute, Lausanne, Switzerland. BCH4 cells are a BALB/c fibroblast
line persistently infected with Long strain RSV (11).
Results
Characterization ofRSV-speck T Cell Line MJC-A2 and CTL Clone E8a.
￿
MJC-A2
T cells were 80% Lyt-2+ , but also contained 20% L3T4+ cells; CTL clone E8a was
exclusively Lyt-2 + and L3T4- . Both the line and clone were dependent on exoge-
nous IL-2 and RSV for growth and lysed P815 cells infected with RSV. Clone E8a
was Kd restricted (71% specific lysis of RSVinfected L-Kd cells), but grew much
slower than the line. Helper T cell function was examined by assaying release of
IL-2 (5) and IL-3 (tested on 32D cells) after antigen stimulation. No IL-2 release
was detected, and only the A2 line released IL-3 (Lin, Y. L., unpublished results).
Although target lysis was specific for RSV the RSV protein(s) recognized by the
T cell line and CTL clone could not be defined. Neither lysed target cells infected
with recombinant vaccinia virus expressing the RSV nucleoprotein, attachment gly-
coprotein, fusion protein, 1B, 1C, or partial matrix (residues 88-256) gene products
(4, 5). It is hoped that antigen specificity will be defined when further VV recom-
binants become available.
Transfer of CTL Augments Disease in Infected BALBIc Mice.
￿
Since irradiated mice
can be persistently infected with RSV (8), we examined whether such infection could
be cleared by transfer of CTL. RSV-infected recipients of the T cell line became
ill within 2-3 d of cell transfer; they lost weight, developed ruffled fur, became tachyp-
noeic, and cyanosed. High mortality resulted, and only one out offive mice survived
to day 5 (Fig. 1). RSV infection alone produced no signs of distress, with a meanm
0
0 z
CANNON ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
1165
~A T-'1
0 1 2 3 4 5 11 12
d
FIGURE 1.
￿
Survival of y-irradiated (500
rad) BALB/c mice after RSV infection
and/or transfer of MJC-A2 T cells at day
0. Mice were irradiated on day -1. Treat-
ments were (O) 105 pfu RSV i.n.,; (/)
8 x 106 MJC-A2 Tc i.v.; (A) 105 pfu RSV
i.n., and 8 x 106 MJC-A2 CTL i.v. RSV
infected mice were killed onday 5 for lung
RSV assays. Mean RSV titre (loglo
pfu/pair of lungs): (O) 4.7 and (A) <1.8
(one survivor at day 5). Mice given MJC-
A2 cells alone showed no signs of illness.
lung RSV titer of4.7 loglo PFU at day 5. Uninfected irradiated mice receiving only
MJC-A2 cells showed no signs of illness.
Sincethe single survivor ofthe RSVinfected group that received MJC-A2 T cells
wasclear oflung viruson day 5, we examined whether transferofreduced numbers
ofCTL could cleara persistent RSV infection without leading to lethal respiratory
disease. In irradiated RSVinfected mice given 106 cells, mean lung RSV titer was
greatly reduced by day 5 (2.0 loglo PFU compared with 4.0 loglo PFU in mice not
given T cells), and on day 10, all mice given T cells were clearofRSV while controls
had 3.5 loglo PFU in the lungs. Transfer of 3 x 105 MJC-A2 cells resulted in clear-
ance by day 10, but gave a much smaller, though significant (p < 0.02), reduction
in lung RSV on day 5, indicating less rapid virus clearance. All mice survived to
day 10, with progressively increasing signs of respiratory distress in infected mice
as the number oftransferred CTL was increased. Uninfected irradiated mice given
3 x 106 cells all appeared well.
Infection of normal BALB/c mice results in peak lung RSV titers on day 4-6;
TABLE I
Transfer ofMJC-A2 Cells and CTL Clone to RSV-infected Mice
Geometric mean and range (in parentheses) of values of various parameters for groups of normal BALB/c
mice subjected to infection and/or CTL transfer. (Exp. 1) Mice were given MJC-A2 cells and groups sub-
jected to bronchoalveolar lavage (BAL) and virus titration at day 5. Two out of five infected mice given 3
x 106 CTL cells died before day 5, and the other three showed respiratory distress. (Exp. 2) Mice were
injected with CTL done E8a; one out of six infected mice given 3 x 106 cells died before day 5, and others
in this group appeared very ill. None ofthe control mice (infected or CTL alone) showed respiratory distress.
Exp. 1 : T line MJC-A2 Exp. 2 : CTL clone E8a
Number of
RSV cells Lung BAL Lung BAL
(i.n.) (i.v. x 10-6) virus PMN Hb virus PMN Hb
loglo PFU % Ng/ml logto PFU % ug/ml
+ 0 3 .9(3.4-4.2) 2.8(0-12) 1.7(0-8) 3.9(3.7-4.1) 5.6(1-17) 8.9(2-33)
+ 1 <1 .8(all) 8.7(0-68) 133(14-930) ND ND ND
+ 3 <1 .8(all) 25.1(12-40) 280(230-310) <1.8(all) 11 .4(4-60) 278(80-1200)
0 3 - 1 .3(0-3) <1(all) - 1 .3(0-3) 3.2(0-54)1166
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thereafter, the virus is rapidly cleared (12). We therefore examined virus titer and
pathology at day 5 in normal mice, a time point bywhich a primary CTL response
is not detectable in the lungs (13). As shown in Table I, transfer of 106 or 3 x 106
MJC-A2 cells to RSVinfected immunocompetent mice efficientlyclearedlung RSV
byday5, but both groups again showed signs ofrespiratory distress. Ofthe infected
mice receiving 3 x 106 MJC-A2 T cells, two out offive were dead by day 5. Patho-
logical effects were monitored by BAL. Although lung hemorrhage was statistically
significant in groups ofinfected mice given either 106 or 3 x 106 T cells (p < 0.01
andp < 0.05, respectively; MannWhitney test) compared with those only infected
with RSV, the groups do not show statistically significant differences in polymor-
phonuclear (PMN) cell counts. There is considerable individual variation in PMN
efflux into BAL, but two out offive and two out ofthree surviving host mice have
exceptionally high PMN counts (30-60%) after transfer of 106 and 3 x 106 A2 T
cells, respectively.
Despite proven pulmonary infection, the control mice not given CTL appeared
well andhadlow Hblevels andPMN counts in BAL, and uninfected mice receiving
MJC-A2 Tcells similarly showed no pathology. Histologicalexaminationofthe lungs
ofinfected Tc recipient mice showed increased peribronchiolar infiltration oflym-
phocytes, monocytes, and PMNs compared with those infected with RSV alone.
In addition, areas ofalveolarconsolidationwith hemorrhage were seen (not shown).
Transfer of CTL clone E8a also led to increased pulmonary disease in im-
munocompetent RSV-infected mice (Table I, Exp. 2). 3 x 106 E8a cells resulted in
clearance of RSV from the lungs of surviving RSV-infected mice by day 5 and a
striking pulmonary hemorrhage (p < 0.01). Again, PMN counts >20% were only
seen in infectedmiceinjected with CTL, but group differences were not statistically
significant. Transfer ofinfluenzaNP-specificCTLclone BA4 (14) intoRSV-infected
mice did not enhance lung pathology (not shown).
Can RSV-speck CTL Be Detected in BAL Cells?
￿
BAL cells were recovered from
thelungs 4 d after RSV infection withorwithout T cell transfer. Nonadherent BAL
cells from uninfected mice receiving the T cell line or from infected nonrecipient
mice showed no cytotoxicity, whereas, the infected T cell recipients showed detect-
able but low cytotoxicity (BCH4 cell lysis of 11.3 t 0.7%, compared with 3.8 ±
0.6% ofuninfected BALB/c fibroblasts at K/T of50:1; not illustrated). RSV-specific
CTL could not be found in the spleens of any of these groups ofmice. CTL can
therefore only be eluted from the lungs of T cell-recipient mice with pulmonary
RSV infection.
Discussion
Ourresultsshow that RSV-specific CTL are ableto eliminatevirus from the lungs
ofRSV-infected mice, and that the rate of virus clearance depends on the number
of cells injected. When large numbers of CTL are injected intravenously (106 or
more), virus clearance is associated with augmented and sometimes lethal pulmo-
nary pathology. Similar results are obtained with cloned CTL and a T cell line, de-
spite the presence ofsome L3T4+ cells in cytotoxic line MJC-A2. Further experi-
ments with the clone were limited by its slow and erratic growth rate in vitro.
Virus-specific CTLhave been shown tobe capable ofmediatingboth virus clear-
ance andimmunopathologyin mice infectedwithlymphocyticchoriomenigitisvirusCANNON ET AL.
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(15). Our results with RSVinfected mice contrast with previous experiments from
this laboratory in which 6-10 x 106 influenza-specific cloned CTL greatly reduced
influenza virus titres in lung and trachea of influenza-infected mice (14) and led to
early reduction ofhistopathological changes in the CTL recipients (Mackenzie, C.,
P M. Taylor, and B. A. Askonas, manuscript in preparation). The augmented hemor-
rhagic lung disease, which we nowdescribe, hasno parallel in influenza infected mice.
One possible reason for these contrasting findings is the different anatomical dis-
tribution of the virus infection. Fluoresceinated antibody to RSV binds to cells in
the bronchial and bronchiolar epithelium and alveolar cells in the lungs of RSV
infected children, Cebusmonkeys, andmice (1, 12). It is suggested that alveolar spread
of viral antigen occurs from the replication site in bronchiolar epithelium. By con-
trast, influenza virus is not found in the alveoli (16). Inflammatory edema and cel-
lular infiltration is more likely to cause disease if it occurs in small airways, since
small changes in caliber will produce large changes in airway resistance. Necrosis
of cells in small airways and alveoli is likely to produce hemorrhage, since blood
and air are separated by very small distances in this zone of the lung.
Patients with RSV-induced bronchiolitis have fewer CD8+ lymphocytes in the pe-
ripheral blood than those with other forms of RSV infection (17), indicating either
that CD8+ cells are depleted or that they are concentrated elsewhere. RSV-specific
CTL are undetectable in the peripheral blood of infants with the most severe RSV
induced bronchiolitis (18). Isolation of RSV-specific CTL (13) and large numbers
of CD8+ Tcells in BAL fluid from the lungs of RSV-infected mice (P J. M. Open-
shaw, unpublished results) supports ourfinding that RSV-specific CTL are concen-
trated in the lungs during pulmonary infection.
The present results point to the fine balance of protective vs. deleterious cellular
effects depending on thelevel ofthe CTL response. We nowhope to examine whether
Th cells are protective or cause pathology similar to that induced by CTL in RSV
infection. It is clearly important to explore the function of T cell subpopulations
in different virus infections during development of protective vaccines in order to
avoid enhancement of subsequent disease.
Summary
We have examined thefunction of class I MHC-restricted cytotoxic T cells in ex-
perimental respiratory syncytial virus (RSV) infection of BALB/c mice by transfer
of T cell line MJC-A2 and CTL clone E8a into RSV-infected mice. The T cell line
cleared pulmonary RSV infection within 5 d in persistently infected 'Y-irradiated
mice, but caused acute respiratory disease. This was only seen in infected mice and
was often lethal after transfer of >3 x 106 CTL. Lower numbers of CTL produced
less severe disease but still cleared lung RSV albeit over a longer time course (up
to 10 d). Clearance of lung RSV in immunocompetent mice by the T cell line and
CTL clone was again accompanied by acute and sometimes lethal respiratory dis-
ease. Bronchoalveolar lavage showed severe lung hemorrhage and frequent neutro-
phil efflux in mice with CTL-augmented disease.
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